bendamustine
Selected indexed studies
- Bendamustine. (Drugs, 2001) [PMID:11368287]
- Bendamustine: A review of pharmacology, clinical use and immunological effects (Review). (Oncol Rep, 2022) [PMID:35506458]
- Bendamustine in multiple myeloma. (Eur J Haematol, 2015) [PMID:26085055]
_Worker-drafted node — pending editorial review._
Connections
bendamustine is a side effect of
Sources
- Bendamustine. (2001) pubmed
- Bendamustine: A review of pharmacology, clinical use and immunological effects (Review). (2022) pubmed
- Bendamustine in multiple myeloma. (2015) pubmed
- Bendamustine: something old, something new. (2010) pubmed
- Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials. (2017) pubmed
- Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia - an updated meta-analysis. (2019) pubmed
- Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose? (2017) pubmed
- Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma. (2014) pubmed
- Bendamustine: rebirth of an old drug. (2009) pubmed
- Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. (2013) pubmed